Alx Oncology Holdings (ALXO) Assets (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Assets data on file, last reported at $178.3 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 47.5% year-over-year to $178.3 million; the trailing twelve-month figure through Mar 2026 stood at $178.3 million (up 47.5% YoY), and the FY2025 full-year result was $59.0 million, down 60.04% from the prior year.
• Assets rose to $178.3 million in Q1 2026, from $59.0 million in the prior quarter.
• In the past five years, Assets ranged from a high of $363.7 million in Q1 2022 to a low of $59.0 million in Q4 2025.
• A 5-year average of $212.8 million and a median of $214.6 million in 2024 frame the typical range for Assets.
• Across the five-year window, Assets sank 60.04% in 2025 and surged 47.5% in 2026, its largest moves.
• Tracing ALXO's Assets over 5 years: stood at $306.5 million in 2022, then fell by 20.86% to $242.6 million in 2023, then sank by 39.08% to $147.8 million in 2024, then slumped by 60.04% to $59.0 million in 2025, then jumped by 202.02% to $178.3 million in 2026.
• Business Quant data shows ALXO's Assets at $178.3 million in Q1 2026, $59.0 million in Q4 2025, and $82.7 million in Q3 2025.